Pityriasis Rosea as a Leading Manifestation of COVID-19 Infection

This report describes a rare case of pityriasis rosea-like eruption in a 52-year-old Thai woman following Oxford/AstraZeneca COVID-19 vaccination, emphasizing the condition does not preclude further vaccinations.

This study documented a variety of skin lesions in COVID-19 patients, indicating that skin rashes might be an early or sole symptom of the disease.

In this review, researchers highlighted that COVID-19 can cause various skin manifestations like maculopapular rashes and "COVID toes," which often precede or appear without respiratory symptoms, suggesting their potential for early detection and prognostic evaluation, especially in severe cases.

This article discusses the challenges of attributing skin manifestations to COVID-19, emphasizing the need for more studies to differentiate virus-specific lesions from nonspecific ones, and reports no new clinical results.

This review discusses the various skin manifestations of COVID-19, aiming to improve early detection and treatment but reports no new clinical results.